ES2686677T3 - Detección de Staphylococcus aureus resistente a meticilina - Google Patents

Detección de Staphylococcus aureus resistente a meticilina Download PDF

Info

Publication number: ES2686677T3
Authority: ES; Spain
Prior art keywords: sccmec; region; meca; primer; module
Prior art date: 2007-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES13169580.1T

Other languages

English (en)

Spanish (es)

Inventor

Corinne Jay

Birgit Deiman

Dianne Van Strijp

Paul Van De Wiel

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biomerieux SA

Original Assignee

Biomerieux SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-21

Filing date

2008-12-19

Publication date

2018-10-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40824947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2686677(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-19 Application filed by Biomerieux SA filed Critical Biomerieux SA

2018-10-19 Application granted granted Critical

2018-10-19 Publication of ES2686677T3 publication Critical patent/ES2686677T3/es

Status Active legal-status Critical Current

2028-12-19 Anticipated expiration legal-status Critical

Links

241000191967 Staphylococcus aureus Species 0.000 title claims abstract description 94
RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 title claims abstract description 41
229960003085 meticillin Drugs 0.000 title claims abstract description 41
238000001514 detection method Methods 0.000 title claims description 99
239000000523 sample Substances 0.000 claims abstract description 229
238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 184
230000003321 amplification Effects 0.000 claims abstract description 183
238000000034 method Methods 0.000 claims abstract description 142
150000007523 nucleic acids Chemical group 0.000 claims abstract description 97
238000006243 chemical reaction Methods 0.000 claims abstract description 92
108091034117 Oligonucleotide Proteins 0.000 claims abstract description 81
108020004707 nucleic acids Proteins 0.000 claims abstract description 77
102000039446 nucleic acids Human genes 0.000 claims abstract description 77
239000013611 chromosomal DNA Substances 0.000 claims abstract description 69
238000003780 insertion Methods 0.000 claims abstract description 36
230000037431 insertion Effects 0.000 claims abstract description 36
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 31
239000007795 chemical reaction product Substances 0.000 claims abstract description 31
125000003729 nucleotide group Chemical group 0.000 claims abstract description 28
239000002773 nucleotide Substances 0.000 claims abstract description 24
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 22
238000013518 transcription Methods 0.000 claims abstract description 19
230000035897 transcription Effects 0.000 claims abstract description 19
239000012472 biological sample Substances 0.000 claims abstract description 15
239000000047 product Substances 0.000 claims abstract description 14
101000743006 Lactococcus lactis subsp. cremoris UPF0177 protein in abiGi 5'region Proteins 0.000 claims description 38
238000000429 assembly Methods 0.000 claims description 5
230000000712 assembly Effects 0.000 claims description 5
108020004414 DNA Proteins 0.000 description 49
101150008979 mecA gene Proteins 0.000 description 30
238000013459 approach Methods 0.000 description 24
238000009396 hybridization Methods 0.000 description 23
238000012360 testing method Methods 0.000 description 17
238000012986 modification Methods 0.000 description 16
230000004048 modification Effects 0.000 description 16
238000003752 polymerase chain reaction Methods 0.000 description 14
239000003153 chemical reaction reagent Substances 0.000 description 11
210000000349 chromosome Anatomy 0.000 description 11
238000005516 engineering process Methods 0.000 description 11
230000002759 chromosomal effect Effects 0.000 description 10
108020005187 Oligonucleotide Probes Proteins 0.000 description 9
239000003550 marker Substances 0.000 description 9
239000002751 oligonucleotide probe Substances 0.000 description 9
102000004190 Enzymes Human genes 0.000 description 7
238000003556 assay Methods 0.000 description 7
239000003795 chemical substances by application Substances 0.000 description 7
108091008146 restriction endonucleases Proteins 0.000 description 7
241000191963 Staphylococcus epidermidis Species 0.000 description 6
108091093088 Amplicon Proteins 0.000 description 5
108090000790 Enzymes Proteins 0.000 description 5
230000010354 integration Effects 0.000 description 5
101150003203 mec gene Proteins 0.000 description 5
241000295644 Staphylococcaceae Species 0.000 description 4
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
238000013461 design Methods 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
239000012634 fragment Substances 0.000 description 4
230000006870 function Effects 0.000 description 4
239000000203 mixture Substances 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
108700039691 Genetic Promoter Regions Proteins 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
241000191940 Staphylococcus Species 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
238000012216 screening Methods 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
101100004560 Bacteroides fragilis ccrA gene Proteins 0.000 description 2
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
101100114777 Brucella suis biovar 1 (strain 1330) crcB2 gene Proteins 0.000 description 2
101710116957 D-alanyl-D-alanine carboxypeptidase Proteins 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
238000002944 PCR assay Methods 0.000 description 2
101710202686 Penicillin-sensitive transpeptidase Proteins 0.000 description 2
206010040047 Sepsis Diseases 0.000 description 2
108010052160 Site-specific recombinase Proteins 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
239000000872 buffer Substances 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
-1 cyclic nucleic acid Chemical class 0.000 description 2
238000005202 decontamination Methods 0.000 description 2
230000003588 decontaminative effect Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000005284 excitation Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
238000007834 ligase chain reaction Methods 0.000 description 2
239000006166 lysate Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000005096 rolling process Methods 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
208000013223 septicemia Diseases 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
101150082072 14 gene Proteins 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
108020000946 Bacterial DNA Proteins 0.000 description 1
GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 1
108010065152 Coagulase Proteins 0.000 description 1
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
241000701867 Enterobacteria phage T7 Species 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
101710203526 Integrase Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
101000735344 Lymantria dispar Pheromone-binding protein 2 Proteins 0.000 description 1
101000773513 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) Uncharacterized protein MK0525 Proteins 0.000 description 1
208000037942 Methicillin-resistant Staphylococcus aureus infection Diseases 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
229930185560 Pseudouridine Natural products 0.000 description 1
PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000191984 Staphylococcus haemolyticus Species 0.000 description 1
208000031650 Surgical Wound Infection Diseases 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000003578 bacterial chromosome Anatomy 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
238000009640 blood culture Methods 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
229960002682 cefoxitin Drugs 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
ZPTBLXKRQACLCR-XVFCMESISA-N dihydrouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)CC1 ZPTBLXKRQACLCR-XVFCMESISA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
206010014665 endocarditis Diseases 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000003446 ligand Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
230000008520 organization Effects 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
150000002960 penicillins Chemical class 0.000 description 1
230000008447 perception Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 1
QQXQGKSPIMGUIZ-AEZJAUAXSA-N queuosine Chemical compound C1=2C(=O)NC(N)=NC=2N([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=C1CN[C@H]1C=C[C@H](O)[C@@H]1O QQXQGKSPIMGUIZ-AEZJAUAXSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000012340 reverse transcriptase PCR Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000003352 sequestering agent Substances 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
238000011895 specific detection Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
239000005451 thionucleotide Substances 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Compounds Of Unknown Constitution (AREA)

ES13169580.1T 2007-12-21 2008-12-19 Detección de Staphylococcus aureus resistente a meticilina Active ES2686677T3 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US868007P	2007-12-21	2007-12-21
US8680P		2007-12-21

Publications (1)

Publication Number	Publication Date
ES2686677T3 true ES2686677T3 (es)	2018-10-19

Family

ID=40824947

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES13169580.1T Active ES2686677T3 (es)	2007-12-21	2008-12-19	Detección de Staphylococcus aureus resistente a meticilina
ES08868000T Active ES2425267T5 (es)	2007-12-21	2008-12-19	Detección de Staphylococcus aureus resistente a meticilina

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ES08868000T Active ES2425267T5 (es)	2007-12-21	2008-12-19	Detección de Staphylococcus aureus resistente a meticilina

Country Status (10)

Country	Link
US (3)	US8367337B2 (fr)
EP (3)	EP2231869B2 (fr)
JP (3)	JP5503552B2 (fr)
CN (1)	CN101918593B (fr)
AU (3)	AU2008343878B2 (fr)
CA (2)	CA3046259C (fr)
ES (2)	ES2686677T3 (fr)
IL (1)	IL206499A (fr)
WO (1)	WO2009085221A2 (fr)
ZA (1)	ZA201005180B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2348042A1 (fr)	2001-06-04	2002-12-04	Ann Huletsky	Sequences permettant de detecter et d'identifier des staphylococcus aureus resistant a la meticilline
US11834720B2 (en)	2005-10-11	2023-12-05	Geneohm Sciences, Inc.	Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
GB0605965D0 (en)	2006-03-24	2006-05-03	Univ East Anglia	Fluorescence based detection of substances
ES2686677T3 (es)	2007-12-21	2018-10-19	Biomerieux Sa	Detección de Staphylococcus aureus resistente a meticilina
WO2011027966A2 (fr) *	2009-09-03	2011-03-10	Seegene, Inc.	Sonde td et ses utilisations
US20110200995A1 (en) *	2009-09-04	2011-08-18	Intelligent Medical Devices, Inc.	Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci
JP5083571B2 (ja) *	2009-12-11	2012-11-28	愛知県	黄色ブドウ球菌の遺伝子型別分類法およびこれに用いるプライマーセット
CN104185790B (zh) *	2011-11-11	2016-09-28	美艾利尔圣地亚哥公司	检测杀细胞的毒素(pvl)的装置和方法
US9394573B2 (en)	2011-12-23	2016-07-19	Biomerieux S.A.	Detection of mecA variant strains of methicillin-resistant Staphylococcus aureus
EP2617836A1 (fr)	2012-01-23	2013-07-24	Steffen Mergemeier	Procédé de détection d'une souche de Staphylococcus aureus positive à la coagulase résistante à la méthicilline
BR112014024888B1 (pt) *	2012-04-06	2023-05-16	Geneohm Sciences Canada, Inc	Composição e método para detectar staphylococcus aureus resistente à meticilina (sarm)
CN103146835B (zh) *	2013-03-25	2015-10-28	华南师范大学	基于nasba的试纸条检测食源致病菌的方法及试剂盒
CN104745688A (zh) *	2015-01-30	2015-07-01	湖北永邦医疗科技有限公司	一种用于检测耐甲氧西林金黄色葡萄球菌耐药基因的引物、探针和试剂盒
KR101721605B1 (ko) *	2015-06-15	2017-03-31	대한민국	신규한 국내형 메티실린-내성 황색포도상구균 균주
EP4289972A1 (fr)	2022-06-09	2023-12-13	Congen Biotechnologie GmbH	Procédé de détection de staphylococcus aureus résistant à la méthicilline

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4213893A (en)	1978-10-12	1980-07-22	Miles Laboratories, Inc.	Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays
DE3041653A1 (de)	1980-11-05	1982-06-09	Hoechst Ag, 6000 Frankfurt	Reaktive haertbare bindemittelmischung und deren verwendung zur herstellung von ueberzuegen
FI63596C (fi)	1981-10-16	1983-07-11	Orion Yhtymae Oy	Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
ATE202801T1 (de)	1983-01-10	2001-07-15	Gen Probe Inc	Verfahren zum nachweis, identifizieren und quantifizieren von organismen und viren
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4965188A (en)	1986-08-22	1990-10-23	Cetus Corporation	Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3689223T2 (de)	1985-05-15	1994-03-03	Amoco Corp	Cytidinanaloga.
US4751177A (en)	1985-06-13	1988-06-14	Amgen	Methods and kits for performing nucleic acid hybridization assays
US4882269A (en)	1985-12-13	1989-11-21	Princeton University	Amplified hybridization assay
CA1340807C (fr)	1988-02-24	1999-11-02	Lawrence T. Malek	Procede d'amplification d'une sequence d'acide nucleique
US5130238A (en)	1988-06-24	1992-07-14	Cangene Corporation	Enhanced nucleic acid amplification process
WO1991001384A1 (fr)	1989-07-11	1991-02-07	Gen-Probe, Incorporated	Methodes d'amplification de sequences d'acides nucleiques faisant appel a un complexe de transcription
US5766849A (en)	1989-07-11	1998-06-16	Gen-Probe Incorporated	Methods of amplifying nucleic acids using promoter-containing primer sequence
CA2020958C (fr)	1989-07-11	2005-01-11	Daniel L. Kacian	Methodes d'amplification de sequences d'acide nucleique
CA2035010C (fr)	1990-01-26	1996-12-10	Keith C. Backman	Methode d'amplification des acides nucleiques cibles applicable aux reactions en chaine a la polymerase et a la ligase
US5210015A (en)	1990-08-06	1993-05-11	Hoffman-La Roche Inc.	Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
ZA936016B (en)	1992-08-24	1994-03-10	Akzo Nv	Method for nucleic acid amplification
US6379897B1 (en) *	2000-11-09	2002-04-30	Nanogen, Inc.	Methods for gene expression monitoring on electronic microarrays
US5702895A (en) *	1995-01-19	1997-12-30	Wakunaga Seiyaku Kabushiki Kaisha	Method and kit for detecting methicillin-resistant Staphylococcus aureus
JP3957338B2 (ja)	1996-02-23	2007-08-15	株式会社カイノス	診断薬
US5994076A (en)	1997-05-21	1999-11-30	Clontech Laboratories, Inc.	Methods of assaying differential expression
ZA989950B (en)	1997-11-17	1999-05-04	Akzo Nobel Nv	Transcription based amplification of double stranded DNA targets
JP2000316574A (ja)	1999-03-10	2000-11-21	Matsushita Seiko Co Ltd	Ｍｒｓａが産生する毒素タンパクの検出方法およびモノクローナル抗体とその断片およびｍｒｓａが産生する毒素タンパク検出用キットおよびモノクローナル抗体を産生するハイブリドーマ
WO2002082086A2 (fr)	2001-03-15	2002-10-17	Jacques Schrenzel	Methode de dectection directe du staphylocoque dore resistant a la methicilline (sarm)
CA2348042A1 (fr) *	2001-06-04	2002-12-04	Ann Huletsky	Sequences permettant de detecter et d'identifier des staphylococcus aureus resistant a la meticilline
DE60210621T2 (de)	2001-07-19	2007-03-08	Infectio Diagnostic (I.D.I.) Inc., Sainte-Foy	Universelle methode und zusammensetzung zur schnellen lysierung von zellen zur freisetzung von nukleinsäuren und ihre detektion
DE60304481T8 (de)	2003-11-07	2007-03-08	Federal Rep. of Germany repr.by the Ministry of Health & Soc.Security, the latter repr. by the Pres. of the Robert Koch Inst.	Verfahren zur Identifizierung von Methicilin resistente Staphylococcus aureus (MRSA)
JP2008507296A (ja)	2004-07-26	2008-03-13	ナノスフェアー　インコーポレイテッド	混合培養物中でメチシリン耐性黄色ブドウ球菌とメチシリン感受性黄色ブドウ球菌とを区別する方法
JP2006271370A (ja)	2005-03-02	2006-10-12	Kitasato Inst:The	黄色ブドウ球菌とメチシリン耐性菌の検出方法及びキット
WO2006111028A1 (fr)	2005-04-21	2006-10-26	Uti Limited Partnership	Reaction en chaine de la polymerase (pcr) pour typage sccmec mrsa
WO2007096702A2 (fr) *	2005-07-25	2007-08-30	Asm Scientific, Inc.	Procédés d'amplification multiple par recombinase-polymérase
EP1922415B1 (fr) *	2005-09-05	2013-12-25	Bio-Rad Innovations	Utilisation de rd9 et is6110 en tant qu'acides nucleiques cibles pour le diagnostic de la tuberculose, et fourniture de cibles is6110 et rd9 adaptees a une utilisation en multiplex
US11834720B2 (en) *	2005-10-11	2023-12-05	Geneohm Sciences, Inc.	Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
US7838221B2 (en) *	2005-10-11	2010-11-23	Geneohm Sciences, Inc.	Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA)
US20090253129A1 (en) *	2005-11-10	2009-10-08	Creighton University	Identification of usa300 community-associated methicillin-resistant staphylococcus aureus
EP1903116A1 (fr)	2006-09-01	2008-03-26	Bundesrepublik Deutschland vertr. d. d. Bundes- ministerium für Gesundheit und Soziale Sicherung letztvertr. d.d. Präs. d. Robert Koch Instituts	Supplémentation du typage du S. aureus résistant a la méthicilline (MRSA) par groupement d' éléments SCCmec basé sur le séquencage directe de la PCR multiplexe
ES2403587T3 (es)	2006-12-29	2013-05-20	Mayo Foundation For Medical Education And Research	Métodos de detección de S. aureus resistente a meticilina, así como cebadores, sondas y kits para los mismos
CA2684570A1 (fr) *	2007-04-19	2008-10-30	Molecular Detection Inc.	Methodes, compositions et kits de detection et d'analyse de bacteries resistantes aux antibiotiques
EP2183391A4 (fr) *	2007-07-31	2010-10-27	Quest Diagnostics Invest Inc	Détection de staphylococcus aureus résistant à la méthicilline et sensible à la méthicilline dans des échantillons biologiques
ES2686677T3 (es)	2007-12-21	2018-10-19	Biomerieux Sa	Detección de Staphylococcus aureus resistente a meticilina
FI121884B (fi)	2008-01-17	2011-05-31	Mobidiag Oy	Menetelmä metisilliiniresistenttien stafylokokkien havaitsemiseksi ja tunnistamiseksi sekä menetelmään tarkoitettu koetin ja testipakkaus

2008
- 2008-12-19 ES ES13169580.1T patent/ES2686677T3/es active Active
- 2008-12-19 WO PCT/US2008/013922 patent/WO2009085221A2/fr not_active Ceased
- 2008-12-19 CA CA3046259A patent/CA3046259C/fr active Active
- 2008-12-19 EP EP08868000.4A patent/EP2231869B2/fr active Active
- 2008-12-19 CN CN200880123825.5A patent/CN101918593B/zh active Active
- 2008-12-19 EP EP13169580.1A patent/EP2657351B1/fr active Active
- 2008-12-19 ES ES08868000T patent/ES2425267T5/es active Active
- 2008-12-19 AU AU2008343878A patent/AU2008343878B2/en active Active
- 2008-12-19 CA CA2709356A patent/CA2709356C/fr active Active
- 2008-12-19 JP JP2010539500A patent/JP5503552B2/ja active Active
- 2008-12-19 US US12/339,471 patent/US8367337B2/en active Active
- 2008-12-19 EP EP18176851.6A patent/EP3434785A1/fr not_active Withdrawn
2010
- 2010-06-20 IL IL206499A patent/IL206499A/en active IP Right Grant
- 2010-07-20 ZA ZA2010/05180A patent/ZA201005180B/en unknown
2012
- 2012-12-28 US US13/729,529 patent/US9273360B2/en active Active
2014
- 2014-03-13 JP JP2014050190A patent/JP2014147388A/ja active Pending
- 2014-07-03 AU AU2014203649A patent/AU2014203649A1/en not_active Abandoned
2016
- 2016-02-02 JP JP2016018097A patent/JP6427512B2/ja active Active
- 2016-02-23 US US15/051,255 patent/US20160177379A1/en not_active Abandoned
- 2016-12-19 AU AU2016277561A patent/AU2016277561C1/en active Active

Also Published As

Publication number	Publication date
ES2425267T5 (es)	2022-07-13
US20130203056A1 (en)	2013-08-08
AU2016277561C1 (en)	2018-11-22
EP2657351A1 (fr)	2013-10-30
CA3046259C (fr)	2022-09-27
EP2231869B1 (fr)	2013-05-29
EP2657351B1 (fr)	2018-06-20
AU2008343878A1 (en)	2009-07-09
AU2008343878B2 (en)	2014-08-07
JP6427512B2 (ja)	2018-11-21
CN101918593A (zh)	2010-12-15
WO2009085221A2 (fr)	2009-07-09
WO2009085221A3 (fr)	2009-12-30
AU2016277561A1 (en)	2017-01-12
EP3434785A1 (fr)	2019-01-30
IL206499A (en)	2015-02-26
CA2709356A1 (fr)	2009-07-09
JP5503552B2 (ja)	2014-05-28
US8367337B2 (en)	2013-02-05
CA2709356C (fr)	2019-08-06
JP2014147388A (ja)	2014-08-21
JP2011507516A (ja)	2011-03-10
US20090203013A1 (en)	2009-08-13
JP2016152800A (ja)	2016-08-25
ES2425267T3 (es)	2013-10-14
IL206499A0 (en)	2010-12-30
EP2231869A4 (fr)	2011-03-30
AU2014203649A1 (en)	2014-07-24
CN101918593B (zh)	2019-02-15
EP2231869A2 (fr)	2010-09-29
US20160177379A1 (en)	2016-06-23
US9273360B2 (en)	2016-03-01
ZA201005180B (en)	2011-03-30
CA3046259A1 (fr)	2009-07-09
AU2016277561B2 (en)	2018-05-17
EP2231869B2 (fr)	2022-05-11

Publication	Publication Date	Title
ES2686677T3 (es)	2018-10-19	Detección de Staphylococcus aureus resistente a meticilina
ES2869285T3 (es)	2021-10-25	Secuencias para la detección e identificación de Staphylococcus aureus resistente a meticilina (SARM) con MREJ de tipo xxi
CN105950778A (zh)	2016-09-21	依赖mert-lamp技术检测粪肠球菌和金黄色葡萄球菌的核苷酸序列
AU2018256562B2 (en)	2021-01-28	Detection of MecA Variant Strains of Methicillin-Resistant Staphylococcus Aureus
ES2929033T3 (es)	2022-11-24	Un método para la detección de Legionella
HK1152080B (zh)	2020-04-17	抗甲氧西林金黄色葡萄球菌的检测
HK1152080A (en)	2012-02-17	Detection of methicillin-resistant staphylococcus aureus